Clinical trial
An Exploratory, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Effect and Safety of Pitolisant in Children and Adolescents With Autism Spectrum Disorders
NCT05953389 is registered in ClinicalTrials.gov with Bioprojet as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Exploratory, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Effect and Safety of Pitolisant in Children and Adolescents With Autism Spectrum Disorders
- Lead sponsor
- Bioprojet
- Phase
- Phase 2
- Overall status
- Active, not recruiting
- Start date
- December 20, 2023
- Completion date
- November 30, 2025
- Enrollment
- 62 (estimated)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.